title: A la carte interferon for hepatitis C?
authors.forename: P
authors.initials: P
authors.lastname: Marcellin
authors.forename: J P
authors.initials: JP
authors.lastname: Benhamou
authors.forename: J
authors.initials: J
authors.lastname: Heathcote
authors.forename: H
authors.initials: H
authors.lastname: Bismuth
authors.forename: V
authors.initials: V
authors.lastname: Desmet
authors.forename: J
authors.initials: J
authors.lastname: Guardia
authors.forename: A
authors.initials: A
authors.lastname: Lok
authors.forename: K H
authors.initials: KH
authors.lastname: Buschenfeld
authors.forename: L
authors.initials: L
authors.lastname: Pagliaro
authors.forename: G
authors.initials: G
authors.lastname: Paumgartner
authors.forename: J
authors.initials: J
authors.lastname: Rodes
authors.forename: S
authors.initials: S
authors.lastname: Sherlock
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D007372:Interferons